Alanine 0 7 0 7 B-clinical_variable
aminotransferase 8 24 8 24 I-clinical_variable
( 25 26 25 26 I-clinical_variable
ALT 26 29 26 29 I-clinical_variable
) 29 30 29 30 I-clinical_variable
( 31 32 31 32 O
serum 32 37 32 37 B-clinical_variable
glutamate 38 47 38 47 I-clinical_variable
pyruvate 48 56 48 56 I-clinical_variable
transaminase 57 69 57 69 I-clinical_variable
[ 70 71 70 71 I-clinical_variable
SGPT 71 75 71 75 I-clinical_variable
] 75 76 75 76 I-clinical_variable
) 76 77 76 77 O
and 78 81 78 81 O
aspartate 82 91 82 91 B-clinical_variable
aminotransferase 92 108 92 108 I-clinical_variable
( 109 110 109 110 I-clinical_variable
AST 110 113 110 113 I-clinical_variable
) 113 114 113 114 I-clinical_variable
( 115 116 115 116 O
serum 116 121 116 121 B-clinical_variable
glutamic 122 130 122 130 I-clinical_variable
oxaloacetic 131 142 131 142 I-clinical_variable
transaminase 143 155 143 155 I-clinical_variable
[ 156 157 156 157 I-clinical_variable
SGOT 157 161 157 161 I-clinical_variable
] 161 162 161 162 I-clinical_variable
) 162 163 162 163 O
equal 164 169 164 169 O
to 170 172 170 172 O
or 173 175 173 175 O
less 176 180 176 180 O
than 181 185 181 185 O
2.5 186 189 186 189 B-upper_bound
x 190 191 190 191 I-upper_bound
upper 192 197 192 197 I-upper_bound
limit 198 203 198 203 I-upper_bound
of 204 206 204 206 I-upper_bound
normal 207 213 207 213 I-upper_bound
( 214 215 214 215 I-upper_bound
ULN 215 218 215 218 I-upper_bound
) 218 219 218 219 I-upper_bound
, 219 220 219 220 O
or 221 223 221 223 O
equal 224 229 224 229 O
to 230 232 230 232 O
or 233 235 233 235 O
less 236 240 236 240 O
than 241 245 241 245 O
4 246 247 246 247 B-lower_bound
x 248 249 248 249 I-lower_bound
ULN 250 253 250 253 I-lower_bound
( 254 255 254 255 O
if 255 257 255 257 O
upon 258 262 258 262 O
judgment 263 271 263 271 O
of 272 274 272 274 O
the 275 278 275 278 O
treating 279 287 279 287 O
physician 288 297 288 297 O
, 297 298 297 298 O
it 299 301 299 301 O
is 302 304 302 304 O
believed 305 313 305 313 O
to 314 316 314 316 O
be 317 319 317 319 O
due 320 323 320 323 O
to 324 326 324 326 O
extramedullary 327 341 327 341 B-cancer
hematopoiesis 342 355 342 355 I-cancer
[ 356 357 356 357 I-cancer
EMH 357 360 357 360 I-cancer
] 360 361 360 361 I-cancer
related 362 369 362 369 O
to 370 372 370 372 O
myelofibrosis 373 386 373 386 B-cancer
[ 387 388 387 388 I-cancer
MF 388 390 388 390 I-cancer
] 390 391 390 391 I-cancer
) 391 392 391 392 O

Anemic 0 6 393 399 B-chronic_disease
patient 7 14 400 407 O
OR 15 17 408 410 O
red 18 21 411 414 B-treatment
blood 22 27 415 420 I-treatment
cell 28 32 421 425 I-treatment
( 33 34 426 427 I-treatment
RBC)-transfusion 34 50 427 443 I-treatment
- 50 51 443 444 O
dependent 51 60 444 453 O
patient 61 68 454 461 O

Creatinine 0 10 462 472 B-clinical_variable
clearance 11 20 473 482 I-clinical_variable
equal 21 26 483 488 O
to 27 29 489 491 O
or 30 32 492 494 O
more 33 37 495 499 O
than 38 42 500 504 O
50 43 45 505 507 B-lower_bound
mL 46 48 508 510 I-lower_bound
/ 48 49 510 511 I-lower_bound
min 49 52 511 514 I-lower_bound

Direct 0 6 515 521 B-clinical_variable
bilirubin 7 16 522 531 I-clinical_variable
equal 17 22 532 537 O
to 23 25 538 540 O
or 26 28 541 543 O
less 29 33 544 548 O
than 34 38 549 553 O
1.5 39 42 554 557 B-upper_bound
x 43 44 558 559 I-upper_bound
ULN 45 48 560 563 I-upper_bound
; 48 49 563 564 O
or 50 52 565 567 O
equal 53 58 568 573 O
to 59 61 574 576 O
or 62 64 577 579 O
less 65 69 580 584 O
than 70 74 585 589 O
2 75 76 590 591 B-upper_bound
x 77 78 592 593 I-upper_bound
ULN 79 82 594 597 I-upper_bound
( 83 84 598 599 O
if 84 86 599 601 O
upon 87 91 602 606 O
judgment 92 100 607 615 O
of 101 103 616 618 O
the 104 107 619 622 O
treating 108 116 623 631 O
physician 117 126 632 641 O
, 126 127 641 642 O
it 128 130 643 645 O
is 131 133 646 648 O
believed 134 142 649 657 O
to 143 145 658 660 O
be 146 148 661 663 O
due 149 152 664 667 O
to 153 155 668 670 O
extramedullary 156 170 671 685 B-chronic_disease
hematopoiesis 171 184 686 699 I-chronic_disease
related 185 192 700 707 O
to 193 195 708 710 O
MF 196 198 711 713 B-chronic_disease
) 198 199 713 714 O

For 0 3 715 718 O
cohort 4 10 719 725 O
of 11 13 726 728 O
patients 14 22 729 737 O
that 23 27 738 742 O
are 28 31 743 746 O
already 32 39 747 754 O
on 40 42 755 757 O
ruxolitinib 43 54 758 769 B-treatment
therapy 55 62 770 777 I-treatment
: 62 63 777 778 O
on 64 66 779 781 O
therapy 67 74 782 789 B-treatment
with 75 79 790 794 I-treatment
ruxolitinib 80 91 795 806 I-treatment
for 92 95 807 810 O
at 96 98 811 813 O
least 99 104 814 819 O
for 105 108 820 823 O
6 109 110 824 825 B-lower_bound
months 111 117 826 832 I-lower_bound
, 117 118 832 833 O
and 119 122 834 837 O
on 123 125 838 840 O
stable 126 132 841 847 O
dose 133 137 848 852 O
for 138 141 853 856 O
last 142 146 857 861 B-upper_bound
2 147 148 862 863 I-upper_bound
months 149 155 864 870 I-upper_bound
, 155 156 870 871 O
before 157 163 872 878 O
starting 164 172 879 887 O
therapy 173 180 888 895 B-treatment
with 181 185 896 900 I-treatment
sotatercept 186 197 901 912 I-treatment

Known 0 5 913 918 O
positive 6 14 919 927 O
for 15 18 928 931 O
human 19 24 932 937 B-chronic_disease
immunodeficiency 25 41 938 954 I-chronic_disease
virus-1 42 49 955 962 I-chronic_disease
( 50 51 963 964 I-chronic_disease
HIV-1 51 56 964 969 I-chronic_disease
) 56 57 969 970 I-chronic_disease
, 57 58 970 971 O
or 59 61 972 974 O
active 62 68 975 981 B-chronic_disease
infection 69 78 982 991 I-chronic_disease
with 79 83 992 996 O
hepatitis 84 93 997 1006 B-chronic_disease
- 93 94 1006 1007 I-chronic_disease
B 94 95 1007 1008 I-chronic_disease
or 96 98 1009 1011 I-chronic_disease
-C 99 101 1012 1014 I-chronic_disease

MPN 0 3 1015 1018 B-cancer
- 3 4 1018 1019 I-cancer
associated 4 14 1019 1029 I-cancer
myelofibrosis 15 28 1030 1043 I-cancer

Major 0 5 1044 1049 B-treatment
surgery 6 13 1050 1057 I-treatment
within 14 20 1058 1064 O
4 21 22 1065 1066 B-upper_bound
weeks 23 28 1067 1072 I-upper_bound
prior 29 34 1073 1078 I-upper_bound
to 35 37 1079 1081 O
day 38 41 1082 1085 B-lower_bound
1 42 43 1086 1087 I-lower_bound

Pregnant 0 8 1088 1096 B-pregnancy

Prior 0 5 1097 1102 B-treatment
sotatercept 6 17 1103 1114 I-treatment

Serious 0 7 1115 1122 B-chronic_disease
medical 8 15 1123 1130 I-chronic_disease
condition 16 25 1131 1140 I-chronic_disease
or 26 28 1141 1143 O
psychiatric 29 40 1144 1155 B-chronic_disease
illness 41 48 1156 1163 I-chronic_disease
that 49 53 1164 1168 O
would 54 59 1169 1174 O
prevent 60 67 1175 1182 O
, 67 68 1182 1183 O
( 69 70 1184 1185 O
as 70 72 1185 1187 O
judged 73 79 1188 1194 O
by 80 82 1195 1197 O
the 83 86 1198 1201 O
treating 87 95 1202 1210 O
physician 96 105 1211 1220 O
) 105 106 1220 1221 O
the 107 110 1222 1225 O
subject 111 118 1226 1233 O
from 119 123 1234 1238 O
signing 124 131 1239 1246 O
the 132 135 1247 1250 O
informed 136 144 1251 1259 O
consent 145 152 1260 1267 O
form 153 157 1268 1272 O
or 158 160 1273 1275 O
any 161 164 1276 1279 O
condition 165 174 1280 1289 O
including 175 184 1290 1299 O
the 185 188 1300 1303 O
presence 189 197 1304 1312 O
of 198 200 1313 1315 O
laboratory 201 211 1316 1326 O
abnormalities 212 225 1327 1340 O
, 225 226 1340 1341 O
which 227 232 1342 1347 O
places 233 239 1348 1354 O
the 240 243 1355 1358 O
subject 244 251 1359 1366 O
at 252 254 1367 1369 O
unacceptable 255 267 1370 1382 O
risk 268 272 1383 1387 O
if 273 275 1388 1390 O
he 276 278 1391 1393 O
/ 278 279 1393 1394 O
she 279 282 1394 1397 O
were 283 287 1398 1402 O
to 288 290 1403 1405 O
participate 291 302 1406 1417 O
in 303 305 1418 1420 O
the 306 309 1421 1424 O
study 310 315 1425 1430 O
or 316 318 1431 1433 O
confounds 319 328 1434 1443 O
the 329 332 1444 1447 O
ability 333 340 1448 1455 O
to 341 343 1456 1458 O
interpret 344 353 1459 1468 O
data 354 358 1469 1473 O
from 359 363 1474 1478 O
the 364 367 1479 1482 O
study 368 373 1483 1488 O

Severe 0 6 1489 1495 O
allergic 7 15 1496 1504 O
or 16 18 1505 1507 O
anaphylactic 19 31 1508 1520 O
reactions 32 41 1521 1530 O
or 42 44 1531 1533 O
hypersensitivity 45 61 1534 1550 O
to 62 64 1551 1553 O
recombinant 65 76 1554 1565 B-allergy_name
proteins 77 85 1566 1574 I-allergy_name
or 86 88 1575 1577 O
excipients 89 99 1578 1588 O
in 100 102 1589 1591 O
the 103 106 1592 1595 O
investigational 107 122 1596 1611 B-allergy_name
product 123 130 1612 1619 I-allergy_name

Symptomatic 0 11 1620 1631 O
congestive 12 22 1632 1642 B-chronic_disease
heart 23 28 1643 1648 I-chronic_disease
failure 29 36 1649 1656 I-chronic_disease
, 36 37 1656 1657 O
unstable 38 46 1658 1666 B-chronic_disease
angina 47 53 1667 1673 I-chronic_disease
, 53 54 1673 1674 O
or 55 57 1675 1677 O
unstable 58 66 1678 1686 O
cardiac 67 74 1687 1694 B-chronic_disease
arrhythmia 75 85 1695 1705 I-chronic_disease

Treatment 0 9 1706 1715 B-treatment
- 9 10 1715 1716 I-treatment
related 10 17 1716 1723 I-treatment
toxicities 18 28 1724 1734 I-treatment
from 29 33 1735 1739 O
prior 34 39 1740 1745 B-treatment
therapies 40 49 1746 1755 I-treatment
must 50 54 1756 1760 O
have 55 59 1761 1765 O
resolved 60 68 1766 1774 O
to 69 71 1775 1777 O
grade 72 77 1778 1783 O
equal 78 83 1784 1789 O
to 84 86 1790 1792 O
or 87 89 1793 1795 O
less 90 94 1796 1800 O
than 95 99 1801 1805 O
1 100 101 1806 1807 B-upper_bound

Uncontrolled 0 12 1808 1820 B-chronic_disease
hypertension 13 25 1821 1833 I-chronic_disease

Use 0 3 1834 1837 O
of 4 6 1838 1840 O
any 7 10 1841 1844 O
MPN 11 14 1845 1848 O
- 14 15 1848 1849 O
associated 15 25 1849 1859 O
myelofibrosis 26 39 1860 1873 B-treatment
- 39 40 1873 1874 I-treatment
directed 40 48 1874 1882 I-treatment
therapy 49 56 1883 1890 I-treatment
within 57 63 1891 1897 O
2 64 65 1898 1899 B-upper_bound
weeks 66 71 1900 1905 I-upper_bound
prior 72 77 1906 1911 I-upper_bound
to 78 80 1912 1914 O
study 81 86 1915 1920 O
day 87 90 1921 1924 O
1 91 92 1925 1926 O

Women 0 5 1927 1932 B-gender
of 6 8 1933 1935 O
childbearing 9 21 1936 1948 O
potential 22 31 1949 1958 O
and 32 35 1959 1962 O
men 36 39 1963 1966 O
must 40 44 1967 1971 O
agree 45 50 1972 1977 B-contraception_consent
to 51 53 1978 1980 I-contraception_consent
using 54 59 1981 1986 I-contraception_consent
medically 60 69 1987 1996 I-contraception_consent
approved 70 78 1997 2005 I-contraception_consent
( 79 80 2006 2007 I-contraception_consent
i.e. 80 84 2007 2011 I-contraception_consent
, 84 85 2011 2012 I-contraception_consent
mechanical 86 96 2013 2023 I-contraception_consent
or 97 99 2024 2026 I-contraception_consent
pharmacological 100 115 2027 2042 I-contraception_consent
) 115 116 2042 2043 I-contraception_consent
contraceptive 117 130 2044 2057 I-contraception_consent
measure 131 138 2058 2065 I-contraception_consent
for 139 142 2066 2069 O
at 143 145 2070 2072 O
least 146 151 2073 2078 O
112 152 155 2079 2082 B-lower_bound
days 156 160 2083 2087 I-lower_bound
following 161 170 2088 2097 O
the 171 174 2098 2101 O
last 175 179 2102 2106 O
dose 180 184 2107 2111 O
of 185 187 2112 2114 O
sotatercept 188 199 2115 2126 O

lactating 0 9 2127 2136 O
female 10 16 2137 2143 B-gender

systolic 0 8 2144 2152 B-clinical_variable
blood 9 14 2153 2158 I-clinical_variable
pressure 15 23 2159 2167 I-clinical_variable
[ 24 25 2168 2169 I-clinical_variable
SBP 25 28 2169 2172 I-clinical_variable
] 28 29 2172 2173 I-clinical_variable
equal 30 35 2174 2179 O
to 36 38 2180 2182 O
or 39 41 2183 2185 O
more 42 46 2186 2190 O
than 47 51 2191 2195 O
140 52 55 2196 2199 B-lower_bound
or 56 58 2200 2202 O
diastolic 59 68 2203 2212 B-clinical_variable
blood 69 74 2213 2218 I-clinical_variable
pressure 75 83 2219 2227 I-clinical_variable
[ 84 85 2228 2229 I-clinical_variable
DBP 85 88 2229 2232 I-clinical_variable
] 88 89 2232 2233 I-clinical_variable
equal 90 95 2234 2239 O
to 96 98 2240 2242 O
or 99 101 2243 2245 O
more 102 106 2246 2250 O
than 107 111 2251 2255 O
90 112 114 2256 2258 B-lower_bound

